Don’t Panic About Trump’s Iran Strategy Just Yet
If You Missed Last Night's NBA Finals Game, You Missed Absolute Cinema
The Truth Is Simple: Democrats Don’t Care About Anything but Gaining Power
Here Is Leftist Government
The 60 Minutes Controversy
The War No One Else Is Fighting
Trump Goes to the NBA Finals — Look Who Attacked Him
Who'll Stop the Fraud?
A Villainous Blueprint for Managed Poverty
Donald Trump Is Personally Making Antitrust Sane Again
When Abortion Has a Face
Washington's Debt Problem Is Every Investor's Problem
The GOP's Quiet Rebellion: What It Means for Trump, Congress and the Supreme...
Nine Convicted in Ohio Drug Ring That Mixed Fentanyl Trafficking With $4.5M COVID-19...
Democrat Calls Republicans Fascists, Wishes He Could 'Run Over' Trump at Congressional Bas...
Tipsheet

The CDC Director Just Gave Us an Updated Vaccine Timeline

The CDC Director Just Gave Us an Updated Vaccine Timeline
AP Photo/Alex Brandon

We've brought you a lot of exciting vaccine news these past few weeks. And there's more of it on Tuesday. Center for Disease Control Director Robert Redfield said Americans should expect a vaccine to be rolled out very, very soon. He predicted the second week of December.

Advertisement

The next question then is, who will be receiving the first doses. He answered that too.

In an interview with Fox News anchor Dana Perino, Redfield shared that the first groups to get the vaccine will probably be "nursing home residents and then some combination of health care providers and individuals at high risk for a poor outcome."

"I do think we'll have about 40 million doses of vaccine before the end of the...year," Redfield continued. "That's enough to vaccinate 20 million people. But then it will continue through January and February and hopefully by March we'll start to see vaccine available for the general public."

Advertisement

Pfizer, who vaccine its been developing with BioNTech has produced a 95 percent efficacy rate, requested an emergency authorization from the FDA. A second vaccine candidate being produced by Moderna isn't too far behind, reporting a 94 percent effectiveness. And then a third, developed by AstraZeneca, is up to 90 percent effective.

The FDA has reportedly scheduled a meeting for Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer's request.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement